Loading

Commentary Open Access
Volume 2 | Issue 3 | DOI: https://doi.org/10.46439/cancerbiology.2.025

Co-infection, re-infection and genetic evolution of SARS-CoV-2: Implications for the COVID-19 pandemic control

  • 1Laboratory of Genetics and Molecular Biology, Department of Biomedicine, Academic Unit of Health Sciences, Federal University of Jataí-UFJ, Jataí, GO, Brazil
+ Affiliations - Affiliations

Corresponding Author

Wagner Gouvêa dos Santos, wagner_santos@ufg.br

Received Date: March 11, 2021

Accepted Date: July 13, 2021

Abstract

The identification of new mutations in SARS-CoV-2 and their roles in the viral fitness towards evolution and survival to face the selective pressure imposed by the human host immune response have become the target of great attention recently. As result, concerns related to the emergence of novel variants with more transmissibility and pathogenic potential have led many countries to apply more restrictive measures to avoid increase in the number of infections and collapse of healthcare systems. Re-infection of apparently recovered individuals and cases of co-infection with different variants have also been the focus of studies aiming to investigate whether the vaccines currently used may also be protective against the new emerging variants. This commentary is intended to extend the findings underlying the questions related to the impact of new mutations or combination of them to the efficacy of the developed vaccines and possible changes in the clinical features of COVID-19.

Keywords

Genome sequencing, SARS-CoV-2, Vaccine, Immunity, Virus evolution, Mutation

Author Information X